News and Opinions  –  2025

80 Years since the Nobel Prize for penicillin: Saving lives, facing resistance

Share the article

2025-12-09

As 2025 marks the 80th anniversary of Sir Alexander Fleming, Sir Ernst Chain, and Lord Howard Florey's 1945 Nobel Prize in Medicine, we reflect on a drug that fundamentally shifted the balance of power between humanity and infectious disease. Yet, this celebration is tempered by the very warning Fleming issued during his acceptance speech: the misuse of antibiotics could select for bacterial resistance, rendering the miracle drug ineffective. Today, this warning is the looming crisis of antibiotic resistance, a threat that is endangering modern medicine.

Dr Alexander Fleming receiving the Nobel Prize for Medicine
Dr Alexander Fleming receiving the Nobel Prize for Medicine. Photo: Sir Alexander Fleming – Photo gallery. NobelPrize.org. Nobel Prize Outreach 2025. Tue. 9 Dec 2025. https://www.nobelprize.org/prizes/medicine/1945/fleming/photo-gallery/

Life before antibiotics

The discovery of penicillin by Sir Alexander Fleming in 1928 remains one of the most critical turning points in human history. To truly appreciate penicillin, we must first look back at the pre-antibiotic era. At the start of the 20th century, infections were the leading cause of death. In the U.S. in 1900, infectious diseases caused one-third of all mortality, with pneumonia, tuberculosis, and diarrheal diseases as the top killers (1) . Simple events like a minor cut, an insect bite, or childbirth frequently led to fatal infections. In many major conflicts, more soldiers succumbed to infected wounds than to combat itself. While pioneers like Pasteur and Lister had established the germ theory and improved hygiene, it was the introduction of effective antibiotics, starting with penicillin’s mass production in the 1940s, that truly changed the odds.

How penicillin transformed medicine

The antibiotic pyramid shows how many types of diseases and surgical procedures often relies on effective antibiotics for example: cancer treatment, surguries, blood infections, maternal care, neonatal care, gonorrhea, urinary tract infections, wound infections.
Antibiotics – The cornerstones of basic and modern medicine. Treatment of infections as well as most modern medicinal procedures relies on functioning antibiotics. The antibiotic pyramid shows how many types of diseases and surgical procedures often relies on effective antibiotics. Idea B. Holloway and Prof. O. Cars. Illustration: ZellOut. Click image to enlarge.

Penicillin and the subsequent development of other antimicrobials didn’t just treat sickness; they enabled entirely new fields of medicine. This transformation can be seen in several key areas:

Wound management

Previously life-threatening injuries became manageable concerns overnight. Infections like sepsis, once a death sentence, could now be successfully treated, transforming battlefield and industrial medicine.

Maternal and child health

Infections remain a major killer of mothers and children in low-income nations, but in high-income countries, antibiotics drastically reduced mortality associated with childbirth and common childhood illnesses, such as pneumonia, diarrhea, and severe ear or throat infections. Vaccinations is also needed to be mentioned here as key for maternal and child health.

Sexually transmitted infections

Antibiotics also transformed the treatment of common STIs such as syphilis and gonorrhoea, which previously caused severe long-term health consequences and widespread transmission.

Complex surgeries

Modern surgery, including procedures like hip replacements and organ transplants, is completely dependent on antibiotics to prevent lethal post-operative infections. Without them, the risk of infection would outweigh the benefit of most complex operations.

Critical care and immunosuppression

Intensive care units (ICUs) and treatments for cancer (chemotherapy) or autoimmune diseases rely on the ability to prevent or quickly treat infections in highly vulnerable, immunosuppressed patients.

The looming threat and the path forward

Photo: Shutterstock.

Despite its remarkable success, this medical revolution is fragile. The vision of a post-antibiotic world is bleak: a massive decrease in global life expectancy, “ordinary” infections becoming untreatable and fatal, and major procedures like chemotherapy and organ transplantation being rendered impossible. Current estimates suggest that antibiotic resistance causes over 1.2 million deaths each year (2), and projections indicate this could rise dramatically by 2050 without urgent action (3).

Preserving the legacy of penicillin requires a complex, multi-faceted strategy that addresses global equity. On one hand, we must focus on the sustainable use of existing drugs, reducing unnecessary consumption in both human and animal health to slow the development of resistance. On the other, we must urgently tackle the issue of access, ensuring that the millions in poorer countries who still lack these life-saving medicines receive them.

Furthermore, we must support the development of new antibiotics, diagnostics, vaccines, and alternative therapies, alongside stronger prevention measures – from infection control and vaccination to water, sanitation and hygiene – and a more efficient end-to-end pipeline to bring these tools to those who need them. Only through coordinated global action can we ensure that future generations continue to benefit from one of medicine’s greatest breakthroughs.

References

1. CDC. Achievements in Public Health, 1900-1999: Control of Infectious Diseases. Morbidity and Mortality Weekly Report (MMWR). 1999; 48(29); 621-629.
2. Murray CGL et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis (2022).
3. Naghavi et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 (2024)

More from "2025"